Clozapine Protects Dopaminergic Neurons from Inflammation-Induced Damage by Inhibiting Microglial Overactivation
Open Access
- 26 August 2011
- journal article
- research article
- Published by Springer Science and Business Media LLC in Journal of Neuroimmune Pharmacology
- Vol. 7 (1), 187-201
- https://doi.org/10.1007/s11481-011-9309-0
Abstract
No abstract availableKeywords
This publication has 63 references indexed in Scilit:
- Microglial MAC1 receptor and PI3K are essential in mediating β-amyloid peptide-induced microglial activation and subsequent neurotoxicityJournal of Neuroinflammation, 2011
- Neuroinflammation is a key player in Parkinson’s disease and a prime target for therapyJournal of Neural Transmission, 2010
- Anti-inflammatory effects of antidepressant and atypical antipsychotic medication for the treatment of major depression and comorbid arthritis: a case reportJournal of Medical Case Reports, 2010
- FcγR-stimulated activation of the NADPH oxidase: phosphoinositide-binding protein p40phox regulates NADPH oxidase activity after enzyme assembly on the phagosomeBlood, 2008
- Squamosamide derivative FLZ protects dopaminergic neurons against inflammation-mediated neurodegeneration through the inhibition of NADPH oxidase activityJournal of Neuroinflammation, 2008
- Formyl-methionyl-leucyl-phenylalanine–Induced Dopaminergic Neurotoxicity via Microglial Activation: A Mediator between Peripheral Infection and Neurodegeneration?Environmental Health Perspectives, 2008
- The fibrin-derived γ377-395 peptide inhibits microglia activation and suppresses relapsing paralysis in central nervous system autoimmune diseaseThe Journal of Experimental Medicine, 2007
- Oxidative Stress During Treatment With First- and Second-Generation AntipsychoticsThe Journal of Neuropsychiatry and Clinical Neurosciences, 2005
- The effects of clozapine on the GSK‐3‐mediated signaling pathwayFEBS Letters, 2004
- Calcium signaling in microglial cellsGlia, 2002